In a remarkable tale of resilience and innovation, a young woman has triumphed over a rare cancer diagnosis with the help of an extraordinary surgical team. Karla Flores, just 19 years old, faced the daunting challenge of two bone tumors, a journey that began when she experienced double vision and received the diagnosis of a chordoma—an unusual tumor affecting the spinal column, diagnosed only about 300 times a year in the U.S.

Upon being referred to the University of Maryland Medical Center, Karla met Dr. Mohammed Labib, the neurosurgeon leading her surgical team. He explained how the malignant tumor was pressing against her cranial nerve, causing her symptoms. In preparation for surgery, Dr. Labib ordered an MRI, which unexpectedly revealed a second chordoma wrapped around her vertebrae, a discovery that left the team astounded.

While the first chordoma required a carefully crafted surgical plan involving two operations, the second posed a greater challenge. Dr. Labib shared how some colleagues suggested a more palliative approach, but he held onto hope for a successful outcome.

After extensive research and practice on skull models, the surgical team devised an innovative technique known as the “third nostril” approach. This groundbreaking method involved accessing the tumor through the right nostril and the periphery of the left eye, which required the removal of a small portion of her cheekbone and eye socket membrane.

The surgery was a true collaboration, with facial reconstructive surgeon Dr. Kalpesh Vakharia making key incisions and head and neck surgeon Dr. Andrea Hebert playing a crucial role in reaching the tumor from behind. It was a complex operation that took 20 hours, but ultimately, it was a resounding success—the tumor was completely removed!

Following the surgery, a spinal surgeon stabilized the affected vertebrae, and a year later, radiation therapy confirmed that Karla was cancer-free. As she continues to recover, she is working with therapists to regain full movement in her eye. Karla's determination shines through in her words: “I keep reminding myself to take one day at a time and know that each step is an accomplishment. I’m also glad I stood my ground and kept looking for help until I found it.”

Dr. Labib is optimistic that the innovative third nostril approach could revolutionize the way surgeons tackle similar tumors in the future. Karla’s incredible journey is a testament to the power of perseverance, teamwork, and the remarkable advances in modern medicine.